Brendan P. Eckelman - 22 May 2024 Form 4 Insider Report for Inhibrx, Inc.

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	INBX	Stock Option (right to buy)	Options Exercise	$85,641	-2,510	-27%	$34.12	6,667	22 May 2024	Common Stock	2,510	$33.63	Direct	F1
transaction	INBX	Stock Option (right to buy)	Options Exercise	$85,300	-2,500	-8.6%	$34.12	26,667	22 May 2024	Common Stock	2,500	$23.30	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	Twenty-five percent (25%) of the total shares subject to the stock option became exercisable on January 15, 2022, with the balance to vest and become exercisable in equal successive monthly installments for thirty-six (36) months thereafter.
F2	Twenty-five percent (25%) of the total shares subject to the stock option became exercisable on January 3, 2024, with the balance to vest and become exercisable in equal successive monthly installments for thirty-six (36) months thereafter.